Evidence map›Paper›PMID 32545685›Full record

ArticleJournal of clinical medicine2020

Feasibility of Gynaecologist Led Lynch Syndrome Testing in Women with Endometrial Cancer.

Neil Aj Ryan, Louise Donnelly, Katie Stocking, D Gareth Evans, Emma J Crosbie

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. A Focused Clinical Review of Lynch Syndrome.Cancer management and research · 2023
    Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Neil Aj RyanDivision of Evolution and Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester M13 9WL, UK.ORCID 0000-0003-3117-3257
Louise DonnellyNightingale and Prevent Breast Cancer Research Unit, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK.ORCID 0000-0002-6570-7272
Katie StockingCentre for Biostatistics, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester M13 9WL, UK.ORCID 0000-0002-4966-2414
D Gareth EvansDivision of Evolution and Genomic Medicine, University of Manchester, St Mary's Hospital, Manchester M13 9WL, UK.ORCID 0000-0002-8482-5784
Emma J CrosbieDivision of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, St Mary's Hospital, Manchester M13 9WL, UK.ORCID 0000-0003-0284-8630

Funding

Department of Health NIHR-CS-012-009Medical Research Council MR/M018431/1National Institute for Health Research IS-BRC-1215-20007National Institute for Health Research NF-SI-0513-10076National Institute for Health Research NIHR-CS-012-009
6 · The paper itself

Abstract

A barrier to Lynch syndrome testing is the need for prior genetic counselling, a resource demanding process for both patients and healthcare services. We explored the impact of gynaecologist led Lynch syndrome testing in women with endometrial cancer. Women were approached before surgery, on the day of surgery or during routine follow up. Lynch syndrome testing was offered irrespective of age, family history or tumour characteristics. Women's reasons for being tested were explored using the Motivations and Concerns for GeNEtic Testing (MACGNET) instrument. The short form State-Trait Anxiety Inventory (STAI-6) was used to measure anxiety levels. Only 3/305 women declined Lynch syndrome testing. In total, 175/220 completed MACGNET and STAI-6 psychological instruments. The consent process took an average of 7min 36sec (SD 5min 16sec) to complete. The point of care at which consent was taken (before, day of surgery, during follow up) did not influence motivation for Lynch syndrome testing. Anxiety levels were significantly lower when women were consented during follow up (mean reversed STAI-6 score 32 vs 42,

Indexed as

anxietyconsentendometrial cancergermline testingLynch syndrome

Identifiers

PMID32545685
PMCPMC7355853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.